These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32543111)

  • 1. Current and potential pharmacological treatment options for insomnia in patients with alcohol use disorder in recovery.
    Roehrs TA; Auciello J; Tseng J; Whiteside G
    Neuropsychopharmacol Rep; 2020 Sep; 40(3):211-223. PubMed ID: 32543111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment and treatment of insomnia in adult patients with alcohol use disorders.
    Brower KJ
    Alcohol; 2015 Jun; 49(4):417-27. PubMed ID: 25957855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological treatment for dual diagnosis: a literature update and a proposal of intervention.
    Vitali M; Mistretta M; Alessandrini G; Coriale G; Romeo M; Attilia F; Rotondo C; Sorbo F; Pisciotta F; Attilia ML; Ceccanti M;
    Riv Psichiatr; 2018; 53(3):160-169. PubMed ID: 29912219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of insomnia in alcohol use disorder.
    Geoffroy PA; Lejoyeux M; Rolland B
    Expert Opin Pharmacother; 2020 Feb; 21(3):297-306. PubMed ID: 31899990
    [No Abstract]   [Full Text] [Related]  

  • 5. What is the role of sedating antidepressants, antipsychotics, and anticonvulsants in the management of insomnia?
    McCall C; McCall WV
    Curr Psychiatry Rep; 2012 Oct; 14(5):494-502. PubMed ID: 22923053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy of insomnia.
    Ioachimescu OC; El-Solh AA
    Expert Opin Pharmacother; 2012 Jun; 13(9):1243-60. PubMed ID: 22578014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suvorexant to treat alcohol use disorder and comorbid insomnia: Plan for a phase II trial.
    Campbell EJ; Norman A; Bonomo Y; Lawrence AJ
    Brain Res; 2020 Feb; 1728():146597. PubMed ID: 31837287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapeutic treatment of nightmares and insomnia in posttraumatic stress disorder: an overview of the literature.
    van Liempt S; Vermetten E; Geuze E; Westenberg H
    Ann N Y Acad Sci; 2006 Jul; 1071():502-7. PubMed ID: 16891608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of Safety and Efficacy of Sleep Medicines in Older Adults.
    Schroeck JL; Ford J; Conway EL; Kurtzhalts KE; Gee ME; Vollmer KA; Mergenhagen KA
    Clin Ther; 2016 Nov; 38(11):2340-2372. PubMed ID: 27751669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agomelatine is effective in reducing insomnia in abstinent alcohol-dependent patients.
    Grosshans M; Mutschler J; Luderer M; Mann K; Kiefer F
    Clin Neuropharmacol; 2014; 37(1):6-8. PubMed ID: 24434525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insomnia treatment in the context of alcohol use disorder: A systematic review and meta-analysis.
    Miller MB; Donahue ML; Carey KB; Scott-Sheldon LAJ
    Drug Alcohol Depend; 2017 Dec; 181():200-207. PubMed ID: 29096290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial.
    Anton RF; Latham P; Voronin K; Book S; Hoffman M; Prisciandaro J; Bristol E
    JAMA Intern Med; 2020 May; 180(5):728-736. PubMed ID: 32150232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insomnia in Alcohol-Dependent Patients: Prevalence, Risk Factors and Acamprosate Effect: An Individual Patient Data Meta-Analysis.
    Perney P; Lehert P
    Alcohol Alcohol; 2018 Sep; 53(5):611-618. PubMed ID: 29617889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gabapentin for the treatment of alcohol use disorder.
    Mason BJ; Quello S; Shadan F
    Expert Opin Investig Drugs; 2018 Jan; 27(1):113-124. PubMed ID: 29241365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European guideline for the diagnosis and treatment of insomnia.
    Riemann D; Baglioni C; Bassetti C; Bjorvatn B; Dolenc Groselj L; Ellis JG; Espie CA; Garcia-Borreguero D; Gjerstad M; Gonçalves M; Hertenstein E; Jansson-Fröjmark M; Jennum PJ; Leger D; Nissen C; Parrino L; Paunio T; Pevernagie D; Verbraecken J; Weeß HG; Wichniak A; Zavalko I; Arnardottir ES; Deleanu OC; Strazisar B; Zoetmulder M; Spiegelhalder K
    J Sleep Res; 2017 Dec; 26(6):675-700. PubMed ID: 28875581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic treatment of pediatric insomnia.
    Owens JA; Moturi S
    Child Adolesc Psychiatr Clin N Am; 2009 Oct; 18(4):1001-16. PubMed ID: 19836701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic options in the treatment of insomnia.
    Erman MK
    J Clin Psychiatry; 2005; 66 Suppl 9():18-23; quiz 42-3. PubMed ID: 16336038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sleep disorders in patients with a neurocognitive disorder].
    Moderie C; Carrier J; Dang-Vu TT
    Encephale; 2022 Jun; 48(3):325-334. PubMed ID: 34916075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic Treatment of Insomnia Disorder: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians.
    Wilt TJ; MacDonald R; Brasure M; Olson CM; Carlyle M; Fuchs E; Khawaja IS; Diem S; Koffel E; Ouellette J; Butler M; Kane RL
    Ann Intern Med; 2016 Jul; 165(2):103-12. PubMed ID: 27136278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological Treatments for Borderline Personality Disorder: A Systematic Review and Meta-Analysis.
    Gartlehner G; Crotty K; Kennedy S; Edlund MJ; Ali R; Siddiqui M; Fortman R; Wines R; Persad E; Viswanathan M
    CNS Drugs; 2021 Oct; 35(10):1053-1067. PubMed ID: 34495494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.